Alcon Inc.
Alcon Inc. (ALC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ALC · as of Jun 8, 2026
Key Statistics
Explore Alcon Inc. Data
alc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 26 · Buy rate: 53.8%
The ALC analyst consensus is Buy, based on ratings from 26 Wall Street analysts over the past 3 months. The average 12-month price target is $81.67, representing +22.24% upside from the current price of $66.81.
Competitors & Peers
alc competitorsALC
A
BDX
CAH
GEHC
HUMStock Performance
Full HistoryAbout Alcon Inc.
Alcon Inc. an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment of…
what is alcon inc. · alc stock overview · alcon inc. company profile · who is alcon inc. ceo · alc NYSE · alcon inc. headquarters · alcon inc. business segments
About Stock Overview & Key Data
Alcon Inc. (ALC) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NYSE since Apr 9, 2019. As of the latest trading session, ALC stock price is $66.81, with a market capitalization of $32.6B. The stock has returned -23.63% over the past 12 months and -15.23% year-to-date.
According to 26 Wall Street analysts, the consensus rating for Alcon Inc. stock is Buy, with an average 12-month price target of $81.67. In fiscal year 2025, Alcon Inc. reported revenue of $10.4B and net income of $980.0M. For detailed data — including Alcon Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Alcon Inc. (ALC) stock price is $66.81. The stock is traded on NYSE under the ticker symbol ALC. The 52-week range is $61.84 – $92.55.